8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
May 6, 2026·SEC
Material company update
May 6, 2026·SEC
Core Scientific, Inc.(CORZ)Earnings, Financials & Key Ratios
CORZ•NASDAQ
$22.36
$7.06B mkt cap·Price updated May 7, 2026
AboutCore Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It provides blockchain infrastructure, software solutions, and services. The company mines digital assets for its own account and provides hosting colocation services for other large-scale miners. It operates in two segments, Equipment Sales and Hosting. The company owns and operates computer equipment that is used to process transactions conducted on one or more blockchain networks in exchange for transaction processing fees rewarded in digital currency assets, commonly referred to as mining; and datacenter facilities to provide colocation and hosting services for distributed ledger technology, also commonly known as blockchain. It also develops blockchain-based platforms and applications, including infrastructure management, security technologies, mining optimization, and recordkeeping. The company is headquartered in Austin, Texas. On December 21, 2022, Core Scientific, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.Show more
- Revenue$319M-37.5%
- EBITDA-$76M-175.1%
- Net Income-$289M+78.1%
- EPS (Diluted)-0.88+82.9%
- Gross Margin11.88%-49.9%
- EBITDA Margin-23.76%-220.2%
- Operating Margin-45.36%-1106.6%
- Net Margin-90.47%+64.9%
- Interest Coverage-44.16-28.2%
CORZ Key Insights
Core Scientific, Inc. (CORZ) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 81 (top 19%)
- ✓Strong 5Y sales CAGR of 39.5%
✗Weaknesses
- ✗Profits declining 88.3% over 5 years
- ✗Negative free cash flow
- ✗Shares diluted 24.3% in last year
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CORZ Price & Volume
Core Scientific, Inc. (CORZ) stock price & volume — 10-year historical chart
Loading chart...
CORZ Growth Metrics
Core Scientific, Inc. (CORZ) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years39.53%
3 Years-20.72%
TTM-13.67%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-28.73%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM76.03%
Return on Capital
10 Years-23.07%
5 Years-29.81%
3 Years-3.23%
Last Year-9.55%
CORZ Recent Earnings
Core Scientific, Inc. (CORZ) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (50%)●Beat Revenue 3/12 qtrs (30%)
Q2 2026Latest
May 6, 2026EPS
$1.06
Est $0.02
-5200.0%
Revenue
$115M
Est $117M
-1.5%
Q2 2026
Mar 2, 2026EPS
$0.29
Est $0.27
-7.4%
Revenue
$80M
Est $119M
-33.0%
Q4 2025
Oct 24, 2025EPS
$0.46
Est $0.07
-558.9%
Revenue
$81M
Est $112M
-27.6%
Q3 2025
Aug 8, 2025EPS
$0.04
Est $0.07
+42.9%
Revenue
$79M
Est $111M
-29.4%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $1.06vs $0.02-5200.0% | $115Mvs $117M-1.5% |
| Q2 2026 | Mar 2, 2026 | $0.29vs $0.27-7.4% | $80Mvs $119M-33.0% |
| Q4 2025 | Oct 24, 2025 | $0.46vs $0.07-558.9% | $81Mvs $112M-27.6% |
| Q3 2025 | Aug 8, 2025 | $0.04vs $0.07+42.9% | $79Mvs $111M-29.4% |
Based on last 12 quarters of dataView full earnings history →
CORZ Peer Comparison
Core Scientific, Inc. (CORZ) competitors in Cloud infrastructure and hosting — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 RIOT | 9.14B | 24.11 | -12.36 | 71.89% | -28.78% | 0.10 | ||
 MARA | 4.83B | 12.70 | -3.44 | 38.2% | -30.54% | 1.05 | ||
 CLSK | 3.58B | 13.98 | 12.48 | 102.21% | -33.25% | -13.75% | 0.38 | |
 CIFR | 8.4B | 20.69 | -9.62 | 48.04% | -115.53% | 3.31 | ||
 BTBT | 589.49M | 1.83 | 9.15 | 264.59% | 21.41% | 0.03 | ||
 HUT | 11.22B | 101.18 | -47.28 | -90.71% | -17.66% | 0.25 | ||
 IREN | 18.86B | 56.85 | 145.77 | 167.65% | 18.65% | 0.53 | ||
 WULF | 10.55B | 24.02 | -114.38 | 102.3% | -228.04% | 2.01 |
Compare CORZ vs Peers
Core Scientific, Inc. (CORZ) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CORZ Income Statement
Core Scientific, Inc. (CORZ) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 59.52M | 60.32M | 544.48M | 640.31M | 502.4M | 510.67M | 319.02M | 354.74M |
| Revenue Growth % | - | 1.34% | 802.66% | 17.6% | -21.54% | 1.65% | -37.53% | -13.67% |
| Cost of Goods Sold | 49M | 50.93M | 305.62M | 631.91M | 378.94M | 389.6M | 281.12M | 295.08M |
| COGS % of Revenue | 82.31% | 84.43% | 56.13% | 98.69% | 75.43% | 76.29% | 88.12% | - |
| Gross Profit | 10.53M▲ 0% | 9.39M▼ 10.8% | 238.86M▲ 2443.2% | 8.4M▼ 96.5% | 123.46M▲ 1369.8% | 121.07M▼ 1.9% | 37.9M▼ 68.7% | 59.79M▲ 0% |
| Gross Margin % | 17.69% | 15.57% | 43.87% | 1.31% | 24.57% | 23.71% | 11.88% | 16.86% |
| Gross Profit Growth % | - | -10.78% | 2443.25% | -96.48% | 1369.75% | -1.94% | -68.7% | - |
| Operating Expenses | 23.02M | 15.72M | 72.22M | 2.12B | 114.5M | 140.27M | 182.6M | 153.26M |
| OpEx % of Revenue | 38.67% | 26.06% | 13.26% | 330.77% | 22.79% | 27.47% | 57.24% | - |
| Selling, General & Admin | 17.54M | 16.32M | 64.55M | 226.01M | 100.93M | 120.42M | 182.6M | 205.96M |
| SG&A % of Revenue | 29.47% | 27.06% | 11.85% | 35.3% | 20.09% | 23.58% | 57.24% | - |
| Research & Development | 5.48M | 5.27M | 7.67M | 26.96M | 7.18M | 11.83M | 0 | 0 |
| R&D % of Revenue | 9.21% | 8.74% | 1.41% | 4.21% | 1.43% | 2.32% | - | - |
| Other Operating Expenses | 0 | -5.88M | 0 | 1.86B | 6.39M | 8.02M | 0 | -2M |
| Operating Income | -11.69M▲ 0% | -6.33M▲ 45.9% | 166.64M▲ 2733.8% | -2.11B▼ 1365.9% | 8.96M▲ 100.4% | -19.2M▼ 314.2% | -144.7M▼ 653.8% | -93.47M▲ 0% |
| Operating Margin % | -19.63% | -10.49% | 30.61% | -329.46% | 1.78% | -3.76% | -45.36% | -26.35% |
| Operating Income Growth % | - | 45.86% | 2733.79% | -1365.93% | 100.42% | -314.22% | -653.79% | - |
| EBITDA | -5.57M | 3.08M | 200M | -1.88B | 105.41M | 100.92M | -75.78M | -47.06M |
| EBITDA Margin % | -9.36% | 5.1% | 36.73% | -294.15% | 20.98% | 19.76% | -23.76% | -13.27% |
| EBITDA Growth % | - | 155.23% | 6402.02% | -1041.72% | 105.6% | -4.25% | -175.09% | -1005.57% |
| D&A (Non-Cash Add-back) | 6.12M | 9.4M | 33.36M | 226.09M | 96.44M | 120.12M | 68.91M | 46.41M |
| EBIT | -11.69M | -7.77M | 107.43M | -2.07B | -159.57M | -1.28B | -144.7M | 31.77M |
| Net Interest Income | -235K | -4.44M | -44.35M | -96.83M | -86.24M | -37.07M | -3.28M | 1.09M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.01M |
| Interest Expense | 235K | 4.44M | 44.35M | 96.83M | 86.24M | 37.07M | 3.28M | 5.77M |
| Other Income/Expense | -235K | -5.88M | -103.56M | -53.86M | -254.76M | -1.29B | -143.34M | -1.12B |
| Pretax Income | -11.92M▲ 0% | -12.21M▼ 2.4% | 63.08M▲ 616.8% | -2.16B▼ 3529.9% | -245.8M▲ 88.6% | -1.31B▼ 434.6% | -288.03M▲ 78.1% | -1.22B▲ 0% |
| Pretax Margin % | -20.03% | -20.24% | 11.58% | -337.87% | -48.93% | -257.34% | -90.29% | -342.65% |
| Income Tax | 0 | 0 | 15.76M | -17.09M | 683K | 859K | 583K | 978K |
| Effective Tax Rate % | 0% | 0% | 24.99% | 0.79% | -0.28% | -0.07% | -0.2% | -0.08% |
| Net Income | -11.92M▲ 0% | -12.21M▼ 2.4% | 47.31M▲ 487.6% | -2.15B▼ 4636.5% | -246.49M▲ 88.5% | -1.32B▼ 433.5% | -288.62M▲ 78.1% | -1.22B▲ 0% |
| Net Margin % | -20.03% | -20.24% | 8.69% | -335.2% | -49.06% | -257.5% | -90.47% | -342.93% |
| Net Income Growth % | - | -2.38% | 487.61% | -4636.52% | 88.52% | -433.5% | 78.05% | -28.73% |
| Net Income (Continuing) | -11.92M | -12.21M | 47.31M | -2.15B | -246.49M | -1.32B | -288.62M | -1.22B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.28▲ 0% | -0.06▲ 78.7% | 0.20▲ 435.0% | -6.30▼ 3250.0% | -0.65▲ 89.7% | -5.14▼ 690.8% | -0.88▲ 82.9% | -3.77▲ 0% |
| EPS Growth % | - | 78.68% | 435.01% | -3250% | 89.68% | -690.77% | 82.88% | 76.03% |
| EPS (Basic) | -0.28 | -0.06 | 0.23 | -6.30 | -0.65 | -5.14 | -0.88 | - |
| Diluted Shares Outstanding | 379.86M | 379.86M | 233.31M | 340.65M | 379.86M | 255.83M | 318.07M | 322.91M |
| Basic Shares Outstanding | 379.86M | 379.86M | 207.26M | 340.65M | 379.86M | 255.83M | 318.07M | 322.91M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
CORZ Balance Sheet
Core Scientific, Inc. (CORZ) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 11.05M | 70.92M | 756.56M | 85.1M | 97.02M | 903.96M | 895.54M | 1.45B |
| Cash & Short-Term Investments | 6.66M | 8.67M | 117.87M | 15.88M | 50.41M | 836.2M | 311.38M | 1.01B |
| Cash Only | 6.66M | 8.67M | 117.87M | 15.88M | 50.41M | 836.2M | 311.38M | 1.01B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 287K | 1.11M | 1.68M | 3.54M | 7.16M | 1.02M | 0 | 0 |
| Days Sales Outstanding | 1.76 | 6.7 | 1.13 | 2.02 | 5.2 | 0.73 | - | 64.47 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.41M | 59.93M | 250.35M | 37.38M | 24.59M | 66.74M | 584.16M | 449.68M |
| Total Non-Current Assets | 150.96M | 154.66M | 1.68B | 722.58M | 615.14M | 694.85M | 1.45B | 1.61B |
| Property, Plant & Equipment | 81.3M | 85.24M | 599.76M | 711.56M | 593.27M | 670.81M | 1.4B | 1.45B |
| Fixed Asset Turnover | 0.73x | 0.71x | 0.91x | 0.90x | 0.85x | 0.76x | 0.23x | 0.29x |
| Goodwill | 58.24M | 58.24M | 1.06B | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.98M | 6.67M | 8.2M | 1.7M | 2.25M | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 7.45M | 4.5M | 18.59M | 9.32M | 19.62M | 24.04M | 50.32M | 298.61M |
| Total Assets | 162.01M▲ 0% | 225.58M▲ 39.2% | 2.44B▲ 981.2% | 807.69M▼ 66.9% | 712.16M▼ 11.8% | 1.6B▲ 124.5% | 2.35B▲ 46.8% | 3.07B▲ 0% |
| Asset Turnover | 0.37x | 0.27x | 0.22x | 0.79x | 0.71x | 0.32x | 0.14x | 0.15x |
| Asset Growth % | - | 39.23% | 981.17% | -66.88% | -11.83% | 124.5% | 46.84% | 444.52% |
| Total Current Liabilities | 19.47M | 69.65M | 320.29M | 186.79M | 488.42M | 134.56M | 781.4M | 2.66B |
| Accounts Payable | 7.5M | 3.06M | 11.62M | 53.64M | 154.75M | 19.27M | 126.11M | 218.86M |
| Days Payables Outstanding | 55.89 | 21.91 | 13.87 | 30.98 | 149.06 | 18.05 | 163.73 | 238.8 |
| Short-Term Debt | 648K | 16.02M | 76M | 36.24M | 124.36M | 16.29M | 0 | 993.94M |
| Deferred Revenue (Current) | 0 | 0 | 141.93M | 78.19M | 9.83M | 18.13M | 127.56M | 430.86M |
| Other Current Liabilities | 8.69M | 47.49M | 4.39M | 1.64M | 6.78M | 69.23M | 527.73M | 1.23B |
| Current Ratio | 0.57x | 1.02x | 2.36x | 0.46x | 0.20x | 6.72x | 1.15x | 1.15x |
| Quick Ratio | 0.57x | 1.02x | 2.36x | 0.46x | 0.20x | 6.72x | 1.15x | 1.15x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | -174.32 |
| Total Non-Current Liabilities | 6.69M | 22.23M | 777.37M | 1.03B | 820.67M | 2.28B | 2.53B | 1.71B |
| Long-Term Debt | 2.09M | 19.86M | 652.21M | 0 | 684.08M | 1.07B | 1.06B | 1.06B |
| Capital Lease Obligations | 3.18M | 2.26M | 62.15M | 720K | 37.26M | 97.85M | 0 | 92.23M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.41M | 103K | 63.01M | 1.03B | 99.33M | 1.11B | 1.47B | 5.15B |
| Total Liabilities | 26.16M | 91.88M | 1.1B | 1.22B | 1.31B | 2.42B | 3.31B | 4.38B |
| Total Debt | 7.49M | 40.29M | 818.81M | 37.73M | 865.54M | 1.2B | 1.06B | 2.06B |
| Net Debt | 837K | 31.62M | 700.93M | 21.85M | 815.14M | 363.57M | 748.95M | 1.05B |
| Debt / Equity | 0.06x | 0.30x | 0.61x | - | - | - | - | -1.57x |
| Debt / EBITDA | - | 13.10x | 4.09x | - | 8.21x | 11.89x | - | -43.68x |
| Net Debt / EBITDA | - | 10.28x | 3.50x | - | 7.73x | 3.60x | - | -22.32x |
| Interest Coverage | -49.73x | -1.75x | 2.42x | -21.34x | -1.85x | -34.45x | -44.16x | 5.50x |
| Total Equity | 135.85M▲ 0% | 133.7M▼ 1.6% | 1.34B▲ 903.1% | -409.35M▼ 130.5% | -596.94M▼ 45.8% | -820.18M▼ 37.4% | -962.74M▼ 17.4% | -1.31B▲ 0% |
| Equity Growth % | - | -1.59% | 903.15% | -130.52% | -45.83% | -37.4% | -17.38% | -689.61% |
| Book Value per Share | 0.36 | 0.35 | 5.75 | -1.20 | -1.57 | -3.21 | -3.03 | -4.04 |
| Total Shareholders' Equity | 135.85M | 133.7M | 1.34B | -409.35M | -596.94M | -820.18M | -962.74M | -1.31B |
| Common Stock | 1K | 1K | 27K | 36K | 36K | 3K | 3K | 3K |
| Retained Earnings | -62.54M | -74.74M | -27.43M | -2.17B | -2.42B | -3.74B | -4.15B | -4.49B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | -10.97M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CORZ Cash Flow Statement
Core Scientific, Inc. (CORZ) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -832K | -23.77M | -56.73M | 205.19M | 65.11M | 42.9M | 278.25M | 278.25M |
| Operating CF Margin % | -1.4% | -39.4% | -10.42% | 32.04% | 12.96% | 8.4% | 87.22% | - |
| Operating CF Growth % | - | -2756.37% | -138.73% | 461.66% | -68.27% | -34.12% | 548.66% | 6654.87% |
| Net Income | -11.92M | -12.21M | 47.31M | -2.15B | -246.49M | -1.32B | -288.62M | -1.22B |
| Depreciation & Amortization | 6.12M | 9.4M | 33.36M | 226.09M | 96.44M | 120.12M | 68.91M | 63.15M |
| Stock-Based Compensation | 2.88M | 3.04M | 38.94M | 182.89M | 58.89M | 51.92M | 98.24M | 99.81M |
| Deferred Taxes | 0 | 0 | 9.53M | -18.52M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -3.59M | -2.87M | -136.36M | 1.88B | -394.77M | 1.21B | -124.82M | 1.11B |
| Working Capital Changes | 5.68M | -21.13M | -49.52M | 78.61M | 551.03M | -27.64M | 524.53M | 507.94M |
| Change in Receivables | -83K | -1.55M | -7.41M | -7.58M | -744K | 659K | 0 | -6K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | -1.77M | -21.99M | 26.71M | 118.6M | -12.27M | 10.78M | 30.95M |
| Cash from Investing | -37.36M | -15.14M | -423.84M | -590.78M | -3M | -95.19M | -740.75M | -1.03B |
| Capital Expenditures | -37.41M | -1.57M | -59.27M | -601.66M | -16.16M | -94.96M | -729M | -1.03B |
| CapEx % of Revenue | 62.85% | 2.6% | 10.89% | 93.96% | 3.22% | 18.6% | 228.51% | - |
| Acquisitions | 0 | -13.67M | -365.21M | 10.85M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 52K | 92K | 645K | -10.82M | 13.16M | -231K | -6.75M | -4.14M |
| Cash from Financing | 28.69M | 40.72M | 603.53M | 306.15M | -44.65M | 819.57M | -63.1M | 912.48M |
| Debt Issued (Net) | -832K | 38.08M | 613.7M | 117.74M | -40.99M | 766.91M | -10.29M | -33.33M |
| Equity Issued (Net) | 0 | 0 | 671.26M | -31.65M | 0 | 55M | 6.91M | 5.53M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -31.65M | 0 | 0 | 0 | 0 |
| Other Financing | 29.53M | 2.64M | -681.43M | 220.06M | -3.66M | -2.34M | -59.73M | 940.28M |
| Net Change in Cash | -9.5M▲ 0% | 1.81M▲ 119.1% | 122.96M▲ 6678.2% | -79.44M▼ 164.6% | 17.47M▲ 122.0% | 767.27M▲ 4292.2% | -525.6M▼ 168.5% | 447.26M▲ 0% |
| Free Cash Flow | -38.24M▲ 0% | -25.33M▲ 33.8% | -116.01M▼ 357.9% | -396.47M▼ 241.8% | 48.95M▲ 112.3% | -52.06M▼ 206.4% | -450.75M▼ 765.7% | -471.2M▲ 0% |
| FCF Margin % | -64.25% | -42% | -21.31% | -61.92% | 9.74% | -10.2% | -141.29% | -132.83% |
| FCF Growth % | - | 33.76% | -357.94% | -241.75% | 112.35% | -206.36% | -765.74% | -175.17% |
| FCF per Share | -0.10 | -0.07 | -0.50 | -1.16 | 0.13 | -0.20 | -1.42 | -1.42 |
| FCF Conversion (FCF/Net Income) | 0.07x | 1.95x | -1.20x | -0.10x | -0.26x | -0.03x | -0.96x | 0.39x |
| Interest Paid | 0 | 2.9M | 38.18M | 86.01M | 0 | 0 | 0 | 7.38M |
| Taxes Paid | 0 | 0 | 9.62M | 5.76M | 0 | 0 | 0 | 204K |
CORZ Key Ratios
Core Scientific, Inc. (CORZ) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -9.06% | 6.42% | -460.65% | - | - | - | 109.08% |
| Return on Invested Capital (ROIC) | -3.14% | 11.32% | -191.24% | 3.08% | - | - | 19.01% |
| Gross Margin | 15.57% | 43.87% | 1.31% | 24.57% | 23.71% | 11.88% | 16.86% |
| Net Margin | -20.24% | 8.69% | -335.2% | -49.06% | -257.5% | -90.47% | -342.93% |
| Debt / Equity | 0.30x | 0.61x | - | - | - | - | -1.57x |
| Interest Coverage | -1.75x | 2.42x | -21.34x | -1.85x | -34.45x | -44.16x | 5.50x |
| FCF Conversion | 1.95x | -1.20x | -0.10x | -0.26x | -0.03x | -0.96x | 0.39x |
| Revenue Growth | 1.34% | 802.66% | 17.6% | -21.54% | 1.65% | -37.53% | -13.67% |
CORZ SEC Filings & Documents
Core Scientific, Inc. (CORZ) SEC filings — annual & quarterly reports (10-K, 10-Q)
CORZ Frequently Asked Questions
Core Scientific, Inc. (CORZ) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Core Scientific, Inc. (CORZ) reported $354.7M in revenue for fiscal year 2025. This represents a 496% increase from $59.5M in 2019.
Core Scientific, Inc. (CORZ) saw revenue decline by 37.5% over the past year.
Core Scientific, Inc. (CORZ) reported a net loss of $1.22B for fiscal year 2025.
Dividend & Returns
Core Scientific, Inc. (CORZ) had negative free cash flow of $471.2M in fiscal year 2025, likely due to heavy capital investments.
Explore More CORZ
Core Scientific, Inc. (CORZ) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates